Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Authors not listed

National Institute of Mental Health (NIMH) · 2021

Abstract

Background: About 5 million adults in the U.S. have Alzheimer s disease or another adult-onset neurodegenerative disorder. Many studies have found that inflammation in the brain contributes to these diseases. Researchers want to find a better way to measure this inflammation. Objective: To learn whether COX-1 and/or COX-2 is elevated in the brains of individuals with neurodegenerative brain disease compared to healthy volunteers. Eligibility: Adults age 18 years and older in good general health who have an adult-onset neurodegenerative dementia, such as AD, FTD, corticobasal syndrome, Huntington s disease, or MCI, ALS and healthy adult volunteers enrolled in protocols 01-M-0254 or 17-M-0181. Design: Participants will be screened with medical history, physical exam with vital signs, and lab tests. They will have a neuropsychological testing. Their heart function will be measured. Participants will have a magnetic resonance imaging (MRI) scan. The MRI scanner is a metal tube surrounded by a strong magnetic field. Participants will lie on a table that slides in and out of the tube. The machine makes noise. Participants will get earplugs. Participants will have 2 PET scans. They will be injected with the study drugs through an intravenous catheter placed in an arm vein. The PET scanner is shaped like a doughnut. Participants will lie on a bed that slides in and out of the scanner. A plastic mask will be molded to their head to keep them from moving. A thin plastic tube will be put into an artery at the wrist or elbow crease area. This will be used to draw blood during the scan. Participants will have 2-5 study visits. Participation lasts 1 week to 4 months, depending on scheduling.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2021). Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease. <em>National Institute of Mental Health (NIMH)</em>. https://clinicaltrials.gov/study/NCT04396873
Vancouver
Anonymous. Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease. National Institute of Mental Health (NIMH). 2021.
BibTeX
@misc{anon2021PhaseS, title = {Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease}, author = {Anonymous}, journal = {National Institute of Mental Health (NIMH)}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings